SEC Form 4 · accession 0001493152-17-011200
Ernexa Therapeutics Inc. · ERNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steve Mitgang
Director
Period of report
Sep 29, 2017
Accepted (ET)
Oct 3, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 29, 2017 | A | 816 | $0.00 | A | 1,813 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This restricted stock grant was issued to the reporting person under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan and pursuant to the NTN Buzztime, Inc. Non-Employee Director Compensation Policy in lieu of a portion of the annual retainer earned by the reporting person in his capacity as a non-employee director of the issuer with respect to the quarter ended September 30, 2017. This restricted stock grant was fully-vested on the date of grant.